Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Autoimmune Disorders

  Free Subscription


14.01.2019

2 BMC Neurol
2 Intern Med
2 J Clin Endocrinol Metab
3 J Neuroimmunol
1 J Neurol
1 J Pediatr Endocrinol Metab
1 Kidney Int
5 Mult Scler
1 N Engl J Med
1 Nat Rev Neurol
4 Neurology
2 PLoS One
1 Thyroid


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Neurol

  1. SAIDA T, Yamamura T, Kondo T, Yun J, et al
    A randomized placebo-controlled trial of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis from East Asia and other countries.
    BMC Neurol. 2019;19:5.
    PubMed     Text format     Abstract available

  2. RAKOCEVIC G, Alexopoulos H, Dalakas MC
    Quantitative clinical and autoimmune assessments in stiff person syndrome: evidence for a progressive disorder.
    BMC Neurol. 2019;19:1.
    PubMed     Text format     Abstract available


    Intern Med

  3. MORINO M, Sekine M, Matsumoto K, Kashima H, et al
    A Diagnostically Challenging Case of Autoimmune Pancreatitis Due to Contamination of the Pathological Specimen with Early Gastric Cancer.
    Intern Med. 2019 Jan 10. doi: 10.2169/internalmedicine.2218.
    PubMed     Text format     Abstract available

  4. HANAOKA H, Iida H, Kiyokawa T, Takakuwa Y, et al
    Hydroxychloroquine Improves the Disease Activity and Allows the Reduction of the Corticosteroid Dose Regardless of Background Treatment in Japanese Patients with Systemic Lupus Erythematosus.
    Intern Med. 2019 Jan 10. doi: 10.2169/internalmedicine.1999.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  5. DJELMIS J, Ivanisevic M, Desoye G, van Poppel M, et al
    Higher cord blood levels of fatty acids in pregnant women with type 1 diabetes mellitus.
    J Clin Endocrinol Metab. 2018 May 1. pii: 4989900. doi: 10.1210/jc.2018-00272.
    PubMed     Text format     Abstract available

  6. SKOV J, Sundstrom A, Ludvigsson JF, Kampe O, et al
    Sex-specific risk of cardiovascular disease in autoimmune Addison's disease - a population-based cohort study.
    J Clin Endocrinol Metab. 2019 Jan 3. pii: 5270381. doi: 10.1210/jc.2018-02298.
    PubMed     Text format     Abstract available


    J Neuroimmunol

  7. EMAMI ALEAGHA MS, Siroos B, Allameh A, Shakiba S, et al
    Calcitriol, but not FGF23, increases in CSF and serum of MS patients.
    J Neuroimmunol. 2018;328:89-93.
    PubMed     Text format     Abstract available

  8. ARAMIDEH KHOUY R, Karampoor S, Keyvani H, Bokharaei-Salim F, et al
    The frequency of varicella-zoster virus infection in patients with multiple sclerosis receiving fingolimod.
    J Neuroimmunol. 2018;328:94-97.
    PubMed     Text format     Abstract available

  9. DEMIR S, Pitarokoili K, Linker R, Gold R, et al
    Immune cell derived BDNF does not mediate neuroprotection of the murine anti-CD52 antibody in a chronic autoimmune mouse model.
    J Neuroimmunol. 2018;328:78-85.
    PubMed     Text format     Abstract available


    J Neurol

  10. HARTUNG HP, Graf J, Kremer D
    Long-term follow-up of multiple sclerosis studies and outcomes from early treatment of clinically isolated syndrome in the BENEFIT 11 study.
    J Neurol. 2019 Jan 4. pii: 10.1007/s00415-018-09169.
    PubMed     Text format     Abstract available


    J Pediatr Endocrinol Metab

  11. KARAVANAKI K, Tsouvalas E, Vakaki M, Soldatou A, et al
    Carotid intima media thickness and associations with serum osteoprotegerin and s-RANKL in children and adolescents with type 1 diabetes mellitus with increased risk for endothelial dysfunction.
    J Pediatr Endocrinol Metab. 2018;31:1169-1177.
    PubMed     Text format     Abstract available


    Kidney Int

  12. DAHAN K, Johannet C, Esteve E, Plaisier E, et al
    Retreatment with rituximab for membranous nephropathy with persistently elevated titers of anti-phospholipase A2 receptor antibody.
    Kidney Int. 2019;95:233-234.
    PubMed     Text format    


    Mult Scler

  13. FUCHS TA, Wojcik C, Wilding GE, Pol J, et al
    Trait Conscientiousness predicts rate of longitudinal SDMT decline in multiple sclerosis.
    Mult Scler. 2019 Jan 7:1352458518820272. doi: 10.1177/1352458518820272.
    PubMed     Text format     Abstract available

  14. JAKIMOVSKI D, Benedict RH, Marr K, Gandhi S, et al
    Lower total cerebral arterial flow contributes to cognitive performance in multiple sclerosis patients.
    Mult Scler. 2019 Jan 9:1352458518819608. doi: 10.1177/1352458518819608.
    PubMed     Text format     Abstract available

  15. PAGANI E, Rocca MA, De Meo E, Horsfield MA, et al
    Structural connectivity in multiple sclerosis and modeling of disconnection.
    Mult Scler. 2019 Jan 9:1352458518820759. doi: 10.1177/1352458518820759.
    PubMed     Text format     Abstract available

  16. ROVIRA A
    Peripheral nervous system involvement in multiple sclerosis.
    Mult Scler. 2017 Feb 1:1352458517693469. doi: 10.1177/1352458517693469.
    PubMed     Text format    

  17. HULST HE, Thompson AJ, Geurts JJ
    The measure tells the tale: Clinical outcome measures in multiple sclerosis.
    Mult Scler. 2017 Feb 1:1352458517690825. doi: 10.1177/1352458517690825.
    PubMed     Text format    


    N Engl J Med

  18. RICE GI, Meyzer C, Bouazza N, Hully M, et al
    Reverse-Transcriptase Inhibitors in the Aicardi-Goutieres Syndrome
    N Engl J Med. 2018;379:2275-7.
    PubMed     Text format    


    Nat Rev Neurol

  19. ROCCA MA, Filippi M
    Targeting progression in multiple sclerosis - an update.
    Nat Rev Neurol. 2019 Jan 4. pii: 10.1038/s41582-018-0127.
    PubMed     Text format    


    Neurology

  20. LEWIS A, Galetta S
    Editors' note: Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
    Neurology. 2019;92:109.
    PubMed     Text format    

  21. SALTONSTALL L
    Reader response: Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
    Neurology. 2019;92:109-110.
    PubMed     Text format    

  22. RAE-GRANT A
    Author response: Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
    Neurology. 2019;92:110-111.
    PubMed     Text format    


  23. Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
    Neurology. 2019;92:112.
    PubMed     Text format    


    PLoS One

  24. GIOVANNETTI AM, Borreani C, Bianchi E, Giordano A, et al
    Participant perspectives of a home-based palliative approach for people with severe multiple sclerosis: A qualitative study.
    PLoS One. 2018;13:e0200532.
    PubMed     Text format     Abstract available

  25. CHAO YH, Chen DY, Lan JL, Tang KT, et al
    Tolerogenic beta2-glycoprotein I DNA vaccine and FK506 as an adjuvant attenuates experimental obstetric antiphospholipid syndrome.
    PLoS One. 2018;13:e0198821.
    PubMed     Text format     Abstract available


    Thyroid

  26. FASSBENDER J, Holthoff HP, Li Z, Ungerer M, et al
    Therapeutic effects of short cyclic and combined epitope peptides in a long-term model of Graves disease and orbitopathy.
    Thyroid. 2019 Jan 8. doi: 10.1089/thy.2018.0326.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: